Article
Variation in the α2A-adrenergic receptor gene and risk of gestational diabetes.
Pharmacogenomics - 1 Oct 2017
Kawai Vivian K, Levinson Rebecca T, Adefurin Abiodun, Kurnik Daniel, Collier Sarah P, Conway Douglas, Stein Charles Michael
Abstract excerpt
AIM: Sympathetic activation suppresses insulin secretion via pancreatic ADRA2A. Because sympathetic activity and insulin demand increase during pregnancy, we tested the hypothesis that ADRA2A variants are associated with gestational diabetes (GDM). PATIENTS & METHODS: Among Caucasian pregnant women without pre-existing diabetes, we genotyped 458 who had GDM and 1537 without GDM for seven ADRA2A variants....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
